19.10
2.91%
0.54
Handel nachbörslich:
19.10
Schlusskurs vom Vortag:
$18.56
Offen:
$18.9065
24-Stunden-Volumen:
2,082
Relative Volume:
0.45
Marktkapitalisierung:
$457.29M
Einnahmen:
$1.70M
Nettoeinkommen (Verlust:
$-47.01M
KGV:
-11.24
EPS:
-1.7
Netto-Cashflow:
$-157.28M
1W Leistung:
+3.24%
1M Leistung:
+3.47%
6M Leistung:
-14.23%
1J Leistung:
-24.06%
Puretech Health Plc Adr Stock (PRTC) Company Profile
Firmenname
Puretech Health Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRTC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
19.10 | 457.29M | 1.70M | -47.01M | -157.28M | -1.70 |
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
Puretech Health Plc Adr Aktie (PRTC) Neueste Nachrichten
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
PureTech Health stock hits 52-week low at $16.81 amid market shifts By Investing.com - Investing.com South Africa
PureTech Health stock hits 52-week low at $16.81 amid market shifts - Investing.com India
PureTech to present at J.P. Morgan Healthcare Conference - Investing.com
PureTech reports positive LYT-200 trial results in AML/MDS - Investing.com
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
South Korea Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
PureTech Health (LON:PRTC) Share Price Crosses Below 50-Day Moving Average of $175.96 - Defense World
Asia Pacific Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Europe Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
PureTech Health: Results of the Tender Offer - StockTitan
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team - Business Wire
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You Should Know - Yahoo Finance
PureTech Announces Annual Results for Year Ended December 31, 2020 - Samoa Observer
Finanzdaten der Puretech Health Plc Adr-Aktie (PRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):